Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Oncolytics Biotech Inc T.ONC

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc is a development stage biopharmaceutical company. It is engaged in the discovery and development of pharmaceutical products for the treatment of cancer.
Price: $0.855 | Change: $-0.045 | %Change: -5.00%
Volume: 244,636 | Day High/Low: N/A/N/A | 52 Week High/Low: 1.79/0.445
View modes: 
0 stars

Really Dumb Stock

Said it before.  Tough to figure this one out.  @ $1.70 thought we were out of the woods.  Crazy.  rate and reply
0 stars

Minutes of the EMA meeting

The Committee agreed that the condition, pancreatic cancer, is a distinct medical entity and meets the criteria for orphan designation. The intention to treat the condition with the medicinal...read more
0 stars

RE: Renmark Calgary meeting

Rok1’s summary of the Renmark Calgary meeting is very informative. The two points that stand out for me are the existing 1 million doses of Reolysin and Brad not caring about the potential delisting...read more
5 stars

Renmark Calgary meeting

I found this on the V2 board. The poster's financial advisor attended the meeting..... Please remember that these are my notes of a discussion between me and my advisor (who attended the meeting...read more
5 stars

2015 AACR

Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® Preclinical Data at the 2015 AACR Annual Meeting CALGARY, April 20, 2015 /CNW/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC) (NASDAQ...read more
0 stars

Orphan Status a two-edged sword

Oncolytics Biotech has a very promising product, and from what I can tell, are still very much in the running if thier funding can hold out until they finish phase III testing.   It seems to me that...read more
5 stars

Oncolytics's Reolysin receives orphan drug designation

It is totally beyond me why the s/p is trading at these incredibly low level....Something must give eventually on the upside.....GLTA   Oncolytics's Reolysin receives orphan drug designation...read more
0 stars

RE:FDA ok for Glioma

Results for All Designations Return to Orphan Designation Search Page Row Num Generic Name Designation Date Orphan Designation 1 pelareorep 02-24-2015 Treatment of fallopian tube cancer ...read more
5 stars

FDA ok for Glioma

According to the FDA web site ONC has been granted orphan status for Pelareorep (reolysin) for the treatment of glioma. Another positive step!  rate and reply
0 stars

50 cent days

Hope we get those + $0.50 days back.  :D This stock trades crazy like.  :O  rate and reply
5 stars

EMA approval?

Several years ago I posted the opinion that the EMA would grant approval before the FDA. With the positive results from Matt Coffey's presentation and the recent news that the EMA was considering a...read more
3 stars

Be Polite: Distance Your Organization

I’m pleased to see that Brad is speaking at the Needham Conference tomorrow. If Needham joined RBC and Cowen to become the third investor health conference to deny Brad the opportunity to peddle...read more
0 stars

Another NR - ODD - Gastric Cancer

http://www.newswire.ca/en/story/1513321/oncolytics-biotech-inc-announces-filing-for-orphan-drug-designation-with-the-u-s-fda-for-gastric-cancer  rate and reply
0 stars

Corporate Presentation April 2015

http://www.oncolyticsbiotech.com/files/doc_presentations/2015/Corporate-Presentation-(April-3-2015)_v001_p09z0i.pdf  rate and reply
0 stars

RE:delist

ONCY can apply for an extension on its NASDAQ listing period, I believe.  rate and reply
0 stars

RE:delist

Only on the Nasdaq. I think BT will have something to to release before then, I hope.  rate and reply
0 stars

delist

Apr27, this will be delisted, right?  rate and reply
0 stars

PREPARE FOR LIFTOFF........ ;-)

  rate and reply
0 stars

RE:Not a stock to buy into !!!!!!

You bothered to hold this whole time then sold right before their first of four corporate presentations across Canada?  rate and reply
0 stars

RE:Not a stock to buy into !!!!!!

whatever....spellcheck dude.  rate and reply